Skip to main content
Heritage Bio Labs · Research use only
Heritage Bio Labs

Research Library

CJC-1295 With DAC research

6 articles to explore, with links to 7 original sources.

About CJC-1295 With DAC

CJC-1295 With DAC is a growth hormone-releasing hormone analogue designed for research on prolonged peptide exposure.

Understand the science

  • How long did growth hormone and IGF-1 change in early human trials?

    CJC-1295 With DAC is an investigational form of a growth hormone–releasing hormone (GHRH) analogue. Its attached drug affinity complex (DAC) allows it to bind to blood proteins. Early studies asked how long the circulating peptide and its effects could be measured in healthy adults.

    2 sources (2005, 2024)

  • What the original albumin-binding experiments established

    CJC-1295 With DAC is an engineered form of growth hormone–releasing factor (GRF), also called growth hormone–releasing hormone. Its drug affinity complex (DAC) was designed to react with the blood protein albumin. The original 2005 development study provides older direct evidence for that design.

    2 sources (2005, 2026)

Explore study findings

  • What an exploratory blood-protein study can establish

    CJC-1295 With DAC is an engineered growth hormone–releasing hormone (GHRH) analogue that links to blood proteins. Researchers have used it in human experiments to perturb the growth hormone pathway and look for measurable changes farther downstream.

    2 sources (2009, 2024)

  • What happened to the trial in HIV-associated visceral obesity?

    CJC-1295 With DAC is a growth hormone–releasing hormone analogue with a protein-binding attachment called a drug affinity complex. A historical phase 2 trial asked whether CJC-1295 could affect visceral obesity in people with HIV.

    2 sources (2005, 2024)

Check methods and identity

  • What a 2026 horse-plasma test detected

    CJC-1295 With DAC is a synthetic analogue of growth hormone–releasing hormone (GHRH) with a drug affinity complex that can form covalent bonds with blood proteins. That attachment raises an analytical question about what a laboratory needs to detect.

    2 sources (2024, 2026)

Interpret the evidence

  • The difference between growth hormone peaks and troughs

    CJC-1295 With DAC is a growth hormone–releasing hormone (GHRH) analogue that attaches to proteins in the blood, extending exposure. A human experiment asked whether sustained stimulation would change the timing or the size of growth hormone pulses.

    2 sources (2006, 2024)

Articles from the Heritage Bio Labs research series, with links to the original sources. For research use only; not medical advice.